
Daxxify (daxibotulinumtoxinA-lanm) is the newest FDA-approved neurotoxin on the market. Unlike traditional neurotoxins, Daxxify uses a proprietary peptide technology instead of human or animal byproducts to stabilize the active molecule. The result is a clean-label injectable that delivers smooth, natural-looking wrinkle reduction with notably longer duration—up to 6 months for many patients.
Daxxify is especially effective for moderate to severe frown lines (glabellar lines) and is an excellent option for clients who want fewer maintenance visits throughout the year.